The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms

被引：7

作者：

Berzoti-Coelho, Maria Gabriela ^{[1
]}

Ferreira, Aline Fernanda ^{[1
,2
]}

Nunes, Natalia de Souza ^{[1
]}

Pinto, Mariana Tomazini ^{[1
,2
]}

Rocha Junior, Maur-Cio Cristiano ^{[1
,2
]}

Simoes, Belinda Pinto ^{[2
,3
]}

Martinez-A, Carlos ^{[4
]}

Souto, Elizabeth Xisto ^{[5
]}

Panepucci, Rodrigo Alexandre ^{[2
,3
]}

Covas, Dimas Tadeu ^{[2
,3
]}

Kashima, Simone ^{[1
,2
]}

Castro, Fabiola Attie ^{[1
,2
]}

机构：

[1] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Clin Anal Toxicol & Food Sci, BR-09500900 Sao Paulo, Brazil

[2] Ctr Cell Based Therapy, Ribeirao Preto, Brazil

[3] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, BR-09500900 Sao Paulo, Brazil

[4] Univ Autonoma Madrid, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Campus Cantoblanco, Madrid, Spain

[5] Hosp Transplantes Euryclides Jesus Zerbini, Sao Paulo, Brazil

来源：

BLOOD CELLS MOLECULES AND DISEASES | 2016年 / 59卷

基金：

巴西圣保罗研究基金会;

关键词：

Myeloproliferative Neoplasms; DIDO; Apoptosis; JAK2(V617F); BCR-ABL1; WORLD-HEALTH-ORGANIZATION; APOPTOSIS-RELATED GENES; JAK2; MUTATION; PRIMARY MYELOFIBROSIS; MYELOID NEOPLASMS; ALLELE BURDEN; IN-VITRO; DISORDERS; CELLS; LEUKEMIA;

D O I：

10.1016/j.bcmd.2016.03.008

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Chronic Myeloid Leukemia (CML), Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Primary Myelofibrosis (PMF) are Myeloproliferative Neoplasms (MPN) characterized by clonal myeloproliferation without cell maturation impairment. CML pathogenesis is associated with the Ph chromosome leading to BCR-ABL tyrosine-kinase constitutive expression. The Ph negative MPN (PV, ET and PMF) are characterized by the mutation JAK2(V617F) of the JAK2 protein in the auto-inhibitory JH2 domain, which is found in most PV patients and in approximately half of ET and PMF patients. Considerable effort is beingmade to understand the role of JAK2(V617F) at the MPN initiation and to clarify the pathogenesis and apoptosis resistance in CML, PV, ET and PMF patients. In the present investigation, we evaluated the Death Inducer-Obliterator (DIDO) (variants DIDO 1, 2 and 3) levels in CML, PV, ET and PMF patients. Our data reported the DIDO1, 2 and 3 differential expressions in Myeloproliferative Neoplasms. (C) 2016 Elsevier Inc. All rights reserved.

引用

页码：25 / 30

页数：6

共 31 条

[1] Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders [J].

Bellanne-Chantelot, Christine ;

Chaumarel, Isabelle ;

Labopin, Myriarn ;

Bellanger, Florence ;

Barbu, Veronique ;

De Toma, Claudia ;

Delhommeau, Frangois ;

Casadevall, Nicole ;

Vainchenker, William ;

Thomas, Gilles ;

Najman, Albert .

BLOOD, 2006, 108 (01) :346-352

[2] Death inducer-obliterator 1 (Didol) is a BMP target gene and promotes BMP-induced melanoma progression [J].

Braig, S. ;

Bosserhoff, A-K .

ONCOGENE, 2013, 32 (07) :837-848

[3] Apoptosis-Related Gene Expression Profile in Chronic Myeloid Leukemia Patients after Imatinib Mesylate and Dasatinib Therapy [J].

Ferreira, Aline Fernanda ;

de Oliveira, Gislane L. V. ;

Tognon, Raquel ;

Collassanti, Maria Dulce S. ;

Zanichelli, Maria Aparecida ;

Hamerschlak, Nelson ;

de Souza, Ana Maria ;

Covas, Dimas Tadeu ;

Kashima, Simone ;

de Castro, Fabiola Attie .

ACTA HAEMATOLOGICA, 2015, 133 (04) :354-364

[4] TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms [J].

Fleischman, Angela G. ;

Aichberger, Karl J. ;

Luty, Samuel B. ;

Bumm, Thomas G. ;

Petersen, Curtis L. ;

Doratotaj, Shirin ;

Vasudevan, Kavin B. ;

LaTocha, Dorian H. ;

Yang, Fei ;

Press, Richard D. ;

Loriaux, Marc M. ;

Pahl, Heike L. ;

Silver, Richard T. ;

Agarwal, Anupriya ;

O'Hare, Thomas ;

Druker, Brian J. ;

Bagby, Grover C. ;

Deininger, Michael W. .

BLOOD, 2011, 118 (24) :6392-6398

[5] Ablation of Dido3 compromises lineage commitment of stem cells in vitro and during early embryonic development [J].

Fuetterer, A. ;

Raya, A. ;

Llorente, M. ;

Izpisua-Belmonte, J. C. ;

de la Pompa, J. L. ;

Klatt, P. ;

Martinez-A, C. .

CELL DEATH AND DIFFERENTIATION, 2012, 19 (01) :132-143

[6] Dido gene expression alterations are implicated in the induction of hematological myeloid neoplasms [J].

Fütterer, A ;

Campanero, MR ;

Leonardo, E ;

Criado, LM ;

Flores, JM ;

Hernandez, JM ;

San Miguel, JF ;

Martinez-A, C .

JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (09) :2351-2362

[7] Death inducer-obliterator 1 triggers apoptosis after nuclear translocation and caspase upregulation [J].

García-Domingo, D ;

Ramírez, D ;

de Buitrago, GG ;

Martínez, C .

MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (09) :3216-3225

[8] DIO-1 is a gene involved in onset of apoptosis in vitro, whose misexpression disrupts limb development [J].

García-Domingo, D ;

Leonardo, E ;

Grandien, A ;

Martínez, P ;

Albar, JP ;

Izpisúa-Belmonte, JC ;

Martínez, C .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (14) :7992-7997

[9] Dido3 PHD Modulates Cell Differentiation and Division [J].

Gatchalian, Jovylyn ;

Fuetterer, Agnes ;

Rothbart, Scott B. ;

Tong, Qiong ;

Rincon-Arano, Hector ;

Sanchez de Diego, Ainhoa ;

Groudine, Mark ;

Strahl, Brian D. ;

Martinez-A, Carlos ;

van Wely, Karel H. M. ;

Kutateladze, Tatiana G. .

CELL REPORTS, 2013, 4 (01) :148-158

[10]

Gotoh A, 1997, Curr Opin Hematol, V4, P3

← 1 2 3 4 →